368 related articles for article (PubMed ID: 37207228)
21. Human gut microbiota and Parkinson's disease.
Pant A; Bisht KS; Aggarwal S; Maiti TK
Prog Mol Biol Transl Sci; 2022; 192(1):281-307. PubMed ID: 36280322
[TBL] [Abstract][Full Text] [Related]
22. Brain-gut-microbiota axis in Parkinson's disease.
Mulak A; Bonaz B
World J Gastroenterol; 2015 Oct; 21(37):10609-20. PubMed ID: 26457021
[TBL] [Abstract][Full Text] [Related]
23. Fiber deprivation and microbiome-borne curli shift gut bacterial populations and accelerate disease in a mouse model of Parkinson's disease.
Schmit KJ; Garcia P; Sciortino A; Aho VTE; Pardo Rodriguez B; Thomas MH; Gérardy JJ; Bastero Acha I; Halder R; Cialini C; Heurtaux T; Ostahi I; Busi SB; Grandmougin L; Lowndes T; Singh Y; Martens EC; Mittelbronn M; Buttini M; Wilmes P
Cell Rep; 2023 Sep; 42(9):113071. PubMed ID: 37676767
[TBL] [Abstract][Full Text] [Related]
24. The role of Toll-like receptors and neuroinflammation in Parkinson's disease.
Heidari A; Yazdanpanah N; Rezaei N
J Neuroinflammation; 2022 Jun; 19(1):135. PubMed ID: 35668422
[TBL] [Abstract][Full Text] [Related]
25. Involvement of Abnormal p-α-syn Accumulation and TLR2-Mediated Inflammation of Schwann Cells in Enteric Autonomic Nerve Dysfunction of Parkinson's Disease: an Animal Model Study.
Jiang W; Cheng Y; Wang Y; Wu J; Rong Z; Sun L; Zhou Y; Zhang K
Mol Neurobiol; 2023 Aug; 60(8):4738-4752. PubMed ID: 37148524
[TBL] [Abstract][Full Text] [Related]
26. Neuroinflammation and protein pathology in Parkinson's disease dementia.
Kouli A; Camacho M; Allinson K; Williams-Gray CH
Acta Neuropathol Commun; 2020 Dec; 8(1):211. PubMed ID: 33272323
[TBL] [Abstract][Full Text] [Related]
27. Reactive microglia enhance the transmission of exosomal α-synuclein via toll-like receptor 2.
Xia Y; Zhang G; Kou L; Yin S; Han C; Hu J; Wan F; Sun Y; Wu J; Li Y; Huang J; Xiong N; Zhang Z; Wang T
Brain; 2021 Aug; 144(7):2024-2037. PubMed ID: 33792662
[TBL] [Abstract][Full Text] [Related]
28. [Advances in Parkinson's disease induced by α-synuclein transmitted through the gut-brain axis].
Zhou J; Wang Z
Sheng Wu Gong Cheng Xue Bao; 2022 Jun; 38(6):2120-2127. PubMed ID: 35786466
[TBL] [Abstract][Full Text] [Related]
29. Roles of α‑synuclein in gastrointestinal microbiome dysbiosis‑related Parkinson's disease progression (Review).
Lei Q; Wu T; Wu J; Hu X; Guan Y; Wang Y; Yan J; Shi G
Mol Med Rep; 2021 Oct; 24(4):. PubMed ID: 34414447
[TBL] [Abstract][Full Text] [Related]
30. Neuroprotective effects of fecal microbiota transplantation on MPTP-induced Parkinson's disease mice: Gut microbiota, glial reaction and TLR4/TNF-α signaling pathway.
Sun MF; Zhu YL; Zhou ZL; Jia XB; Xu YD; Yang Q; Cui C; Shen YQ
Brain Behav Immun; 2018 May; 70():48-60. PubMed ID: 29471030
[TBL] [Abstract][Full Text] [Related]
31. The role of gut dysbiosis in Parkinson's disease: mechanistic insights and therapeutic options.
Wang Q; Luo Y; Ray Chaudhuri K; Reynolds R; Tan EK; Pettersson S
Brain; 2021 Oct; 144(9):2571-2593. PubMed ID: 33856024
[TBL] [Abstract][Full Text] [Related]
32. Gut-microbiome-brain axis: the crosstalk between the vagus nerve, alpha-synuclein and the brain in Parkinson's disease.
Claudino Dos Santos JC; Oliveira LF; Noleto FM; Gusmão CTP; Brito GAC; Viana GSB
Neural Regen Res; 2023 Dec; 18(12):2611-2614. PubMed ID: 37449597
[TBL] [Abstract][Full Text] [Related]
33. Picomolar concentrations of oligomeric alpha-synuclein sensitizes TLR4 to play an initiating role in Parkinson's disease pathogenesis.
Hughes CD; Choi ML; Ryten M; Hopkins L; Drews A; Botía JA; Iljina M; Rodrigues M; Gagliano SA; Gandhi S; Bryant C; Klenerman D
Acta Neuropathol; 2019 Jan; 137(1):103-120. PubMed ID: 30225556
[TBL] [Abstract][Full Text] [Related]
34. Nigral overexpression of α-synuclein in a rat Parkinson's disease model indicates alterations in the enteric nervous system and the gut microbiome.
O'Donovan SM; Crowley EK; Brown JR; O'Sullivan O; O'Leary OF; Timmons S; Nolan YM; Clarke DJ; Hyland NP; Joyce SA; Sullivan AM; O'Neill C
Neurogastroenterol Motil; 2020 Jan; 32(1):e13726. PubMed ID: 31576631
[TBL] [Abstract][Full Text] [Related]
35. Exploring the multifactorial aspects of Gut Microbiome in Parkinson's Disease.
Pavan S; Prabhu AN; Prasad Gorthi S; Das B; Mutreja A; Shetty V; Ramamurthy T; Ballal M
Folia Microbiol (Praha); 2022 Oct; 67(5):693-706. PubMed ID: 35583791
[TBL] [Abstract][Full Text] [Related]
36. Chronic stress-induced gut dysfunction exacerbates Parkinson's disease phenotype and pathology in a rotenone-induced mouse model of Parkinson's disease.
Dodiya HB; Forsyth CB; Voigt RM; Engen PA; Patel J; Shaikh M; Green SJ; Naqib A; Roy A; Kordower JH; Pahan K; Shannon KM; Keshavarzian A
Neurobiol Dis; 2020 Feb; 135():104352. PubMed ID: 30579705
[TBL] [Abstract][Full Text] [Related]
37. Unraveling the gut-brain axis: the impact of steroid hormones and nutrition on Parkinson's disease.
Neufeld PM; Nettersheim RA; Matschke V; Vorgerd M; Stahlke S; Theiss C
Neural Regen Res; 2024 Oct; 19(10):2219-2228. PubMed ID: 38488556
[TBL] [Abstract][Full Text] [Related]
38. Gut-brain axis and the spread of α-synuclein pathology: Vagal highway or dead end?
Breen DP; Halliday GM; Lang AE
Mov Disord; 2019 Mar; 34(3):307-316. PubMed ID: 30653258
[TBL] [Abstract][Full Text] [Related]
39. Targeting Microglial α-Synuclein/TLRs/NF-kappaB/NLRP3 Inflammasome Axis in Parkinson's Disease.
Li Y; Xia Y; Yin S; Wan F; Hu J; Kou L; Sun Y; Wu J; Zhou Q; Huang J; Xiong N; Wang T
Front Immunol; 2021; 12():719807. PubMed ID: 34691027
[TBL] [Abstract][Full Text] [Related]
40. Bidirectional gut-to-brain and brain-to-gut propagation of synucleinopathy in non-human primates.
Arotcarena ML; Dovero S; Prigent A; Bourdenx M; Camus S; Porras G; Thiolat ML; Tasselli M; Aubert P; Kruse N; Mollenhauer B; Trigo Damas I; Estrada C; Garcia-Carrillo N; Vaikath NN; El-Agnaf OMA; Herrero MT; Vila M; Obeso JA; Derkinderen P; Dehay B; Bezard E
Brain; 2020 May; 143(5):1462-1475. PubMed ID: 32380543
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
